Area of research
Surgery · Cancer Research
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Cancer, Lipids, and Metabolism, Atherosclerosis and Cardiovascular Diseases, and Diabetes, Cardiovascular Risks, and Lipoproteins.
Effect of Semaglutide on Body Weight, Blood Lipid Profile, and Adipokine Status in Obese Patients.
Lipoprotein(a) Concentration and Achieving Target Values of Low-Density Lipoprotein Cholesterol Calculated by Different Equations.
Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement
Lipoprotein(a) and Blood Monocytes as Factors for Progression of Carotid Atherosclerosis in Patients with Premature Coronary Heart Disease.
The Mysterious Masks of Hypercholesterolemia: A Unique Clinical Case.
Role of Lipoprotein(a) and Blood Cells Ratios in Peripheral Artery Disease.
iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia.
[A clinical case of reverse left ventricular remodeling in patient with pathogenic TTN mutation. Case report].
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook
Comparative Efficacy and Safety of Statin Monotherapy and Statin plus Ezetimibe Combination in a Real-World Setting.
Lipoprotein(a) in an adult sample from the Russian population: distribution and association with atherosclerotic cardiovascular diseases.
Calling and Phasing of Single-Nucleotide and Structural Variants of the <i>LDLR</i> Gene Using Oxford Nanopore MinION.
Clearance and Utilization of Dicarbonyl-Modified LDL in Monkeys and Humans.
The Concentration of PCSK9-Lp(a) Complexes and the Level of Blood Monocytes in Males with Coronary Atherosclerosis.
Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis.
Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease.
Retrospective Analysis of Lipid-Lowering and Antiplatelet Therapy Regimen by Clinical Decision Support Service Based on Real-World Data from Electronic Medical Records "Intellect 3 Study".
iPSC-Derived Endothelial Cells Reveals LDLR-Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia
The Concentration of PCSK9-Lp(a) Complexes and the Level of Blood Monocytes in Males with Coronary Atherosclerosis
[Cardiovascular effects of omega-3 polyunsaturated fatty acids: position of omega-3 polyunsaturated fatty acids in Russian and international guidelines. Council of Experts].
World Heart Federation Cholesterol Roadmap 2022
Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease.
Projected impact of treatment intensification with statin, ezetimibe, and statin plus ezetimibe fixed-dose combination on MACE across six countries.
A Clinical Case of a Homozygous Deletion in the <i>APOA5</i> Gene with Severe Hypertriglyceridemia.
Hyperlipoproteinemia(a) and Severe Coronary Artery Lesion Types.
Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis.
[The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients].
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)
The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis.
Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries.